OBJECTIVES: In clinical practice, internal urethrotomy is an easy procedure and is offered as a first modality for treatment of short urethral strictures. Internal urethrotomy refers to any procedure that opens the stricture by incising or ablating it transurethrally. The most common complication of internal urethrotomy is stricture recurrence. The curative success rate of internal urethrotomy is approximately 20%. Triamcinolone has antifibroblast and anticollagen properties. This study evaluated the efficacy of triamcinolone in the prevention of anterior urethral stricture recurrence after internal urethrotomy. METHODS:Fifty male patients with anterior urethral stricture were randomized to undergo internal urethrotomy with or without urethral submucosal injection of triamcinolone. Using general anesthesia urethrotomy was performed. Triamcinolone (40 mg) was injected submucosally at the urethrotomy site in 25 patients. The patients were followed for at least 12 months and the stricture recurrence rate was compared between the two groups. RESULTS:23 patients in thetriamcinolone group and 22 in the control group completed the study. There were no significant differences in the baseline characteristics of the patients or the etiology of the stricture between the two groups. Mean follow-up time was 13.7 ± 5.5 months (range: 1-25 months). Urethral stricture recurred in five patients (21.7%) in the triamcinolone group and in 11 patients (50%) in the control group (P = 0.04). CONCLUSIONS: Injection of triamcinolone significantly reduced stricture recurrence after internal urethrotomy. Further investigations are warranted to confirm its efficacy and safety.
RCT Entities:
OBJECTIVES: In clinical practice, internal urethrotomy is an easy procedure and is offered as a first modality for treatment of short urethral strictures. Internal urethrotomy refers to any procedure that opens the stricture by incising or ablating it transurethrally. The most common complication of internal urethrotomy is stricture recurrence. The curative success rate of internal urethrotomy is approximately 20%. Triamcinolone has antifibroblast and anticollagen properties. This study evaluated the efficacy of triamcinolone in the prevention of anterior urethral stricture recurrence after internal urethrotomy. METHODS: Fifty male patients with anterior urethral stricture were randomized to undergo internal urethrotomy with or without urethral submucosal injection of triamcinolone. Using general anesthesia urethrotomy was performed. Triamcinolone (40 mg) was injected submucosally at the urethrotomy site in 25 patients. The patients were followed for at least 12 months and the stricture recurrence rate was compared between the two groups. RESULTS: 23 patients in the triamcinolone group and 22 in the control group completed the study. There were no significant differences in the baseline characteristics of the patients or the etiology of the stricture between the two groups. Mean follow-up time was 13.7 ± 5.5 months (range: 1-25 months). Urethral stricture recurred in five patients (21.7%) in the triamcinolone group and in 11 patients (50%) in the control group (P = 0.04). CONCLUSIONS: Injection of triamcinolone significantly reduced stricture recurrence after internal urethrotomy. Further investigations are warranted to confirm its efficacy and safety.
Authors: Ali Al-Attar; Sarah Mess; John Michael Thomassen; C Lisa Kauffman; Steven P Davison Journal: Plast Reconstr Surg Date: 2006-01 Impact factor: 4.730
Authors: Jack I Ramage; Ashwin Rumalla; Todd H Baron; Nicole L Pochron; Alan R Zinsmeister; Joseph A Murray; Ian D Norton; Nancy Diehl; Yvonne Romero Journal: Am J Gastroenterol Date: 2005-11 Impact factor: 10.864
Authors: Clemens M Rosenbaum; Marianne Schmid; Tim A Ludwig; Luis A Kluth; Philip Reiss; Roland Dahlem; Oliver Engel; Felix K-H Chun; Silke Riechardt; Margit Fisch; Sascha A Ahyai Journal: World J Urol Date: 2014-11-27 Impact factor: 4.226
Authors: Rachel A Mann; Ramón Virasoro; Jessica M DeLong; Rafael E Estrella; Merycarla Pichardo; Ramón Rodríguez Lay; Gustavo Espino; Joshua D Roth; Sean P Elliott Journal: Can Urol Assoc J Date: 2021-02 Impact factor: 1.862
Authors: Eliseo Portilla-de Buen; Juan Pablo Ramirez-Contreras; Jonathan Matias Chejfec-Ciociano; Rodrigo Lopez-Falcony; David Garcia-Martinez; Jose Gonzalo Vazquez-Camacho; Clotilde Fuentes-Orozco; Francisco Jose Barbosa-Camacho; Juan Carlos Ibarrola-Peña; Alejandro Gonzalez-Ojeda Journal: Res Rep Urol Date: 2021-05-14
Authors: Keith F Rourke; Blayne Welk; Ron Kodama; Greg Bailly; Tim Davies; Nancy Santesso; Philippe D Violette Journal: Can Urol Assoc J Date: 2020-10 Impact factor: 2.052